Recursion Pharmaceuticals Inc Clinical-stage biotechnology company Recursion Pharmaceuticals Inc. (NASDAQ: RXRX) saw its stock double on the announcement of a $50 million investment from artificial intelligence (AI) leader Nvidia Co. (Nasdaq: NVDA). Nvidia Invested $50 million into This AI Drug Discovery Biotech www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discovery-biotech www.nasdaq.com/articles/nvidia-invested-$50-million-into-this-ai-drug-discover…
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.